Skip to main content
2024 ISPE Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Tobias Gerhard, PhD (he/him/his)

Professor and Director
Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research
New Brunswick, United States

Tobias Gerhard is a pharmacoepidemiologist at Rutgers University. He is the Founding Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS) and currently serves as Director of the Rutgers Institute for Health. He received his pharmacy degree from the University of Freiburg, Germany (2002), and his PhD in pharmacoepidemiology from the University of Florida (2007). Dr. Gerhard’s work focuses on the development and evaluation of modern pharmacoepidemiologic methods with applications in mental health and geriatric pharmacotherapy. He has extensive experience working with large claims and electronic health record datasets and has published widely on use, safety, and outcomes of therapeutics, particularly of psychotropic medications in vulnerable populations. His work has been funded by NIA, NIMH, AHRQ, PCORI, and by multiple foundations. His work has been recognized with a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation, a NCDEU New Investigator Award from the American Society of Clinical Psychopharmacology, and the 2020 Sternfels Prize for Drug Safety Discoveries. Dr. Gerhard is a Fellow of the International Society for Pharmacoepidemiology (ISPE) and the Society's immediate past President. He serves on committees for FDA and the National Academies of Sciences, Engineering, and Medicine (NASEM).

Disclosure information not submitted.

Presentation(s):

Email Tobias